Concepedia

Olivier Grenet

OG

25

Publications

1.8K

Citations

19

H-Index

1998

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

National Institute of Environmental Health Sciences

Bayer (Germany)

Olivier Grenet is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and immunology.

Top concepts

Publications per year

1998–2021

25

Publications

25

Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury

Frank Dieterle, Elias Perentes, André Cordier et al. · Nature Biotechnology · 2010 · 329 citations

, , +13

A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function

Josef Ozer, Frank Dieterle, Sean P. Troth et al. · Nature Biotechnology · 2010 · 202 citations

, , +11

Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFκB

David Cappellen, Ngoc-Hong Luong-Nguyen, Sandrine Bongiovanni et al. · Journal of Biological Chemistry · 2002 · 184 citations · Full text

The PKC inhibitor AEB071 may be a therapeutic option for psoriasis

Hans Skvara, Markus Dawid, Elise Kleyn et al. · Journal of Clinical Investigation · 2008 · 160 citations · Full text

, , +17

New insights into cyclosporine A nephrotoxicity by proteome analysis

Lothar Aicher, Daniel Wahl, Olivier Grenet et al. · Electrophoresis · 1998 · 102 citations

Rows per page

1–5 of 25